Recommended Pain Management for Immobile Patient with Shoulder, Buttock, and Lower Back Pain
Start with NSAIDs (such as naproxen sodium) as first-line therapy, combined with a skeletal muscle relaxant for short-term use if the pain is acute, and consider adding acetaminophen to the NSAID regimen for enhanced pain relief.
Primary Pharmacologic Approach
For your immobile patient experiencing multi-site musculoskeletal pain, the evidence strongly supports NSAIDs as the cornerstone of treatment:
NSAIDs are the only first-line pharmacological option supported by guidelines for both acute and chronic low back pain 1. The most recent evidence from 2024 specifically highlights naproxen sodium as particularly effective due to its 14-hour half-life, providing sustained all-day pain relief with reduced pill burden compared to shorter-acting options 2.
Add acetaminophen to the NSAID regimen rather than using it alone. The 2023 systematic review demonstrates that NSAIDs combined with paracetamol (acetaminophen) produce greater improvement than NSAIDs alone, while acetaminophen alone is ineffective 3. This directly contradicts older recommendations and is critical—acetaminophen was found ineffective as monotherapy for acute low back pain 1.
Muscle Relaxants for Acute Pain
If the pain is acute (less than 4 weeks duration):
- Add a skeletal muscle relaxant for short-term relief only 1, 3. These are effective for acute low back pain but cause sedation as a common side effect 1.
- Limit muscle relaxant use to the shortest duration possible because evidence does not support improved functional recovery, and they introduce adverse events without significantly reducing pain long-term 2.
- Do not use muscle relaxants for chronic pain—the evidence does not support this 1.
What to Avoid
Do NOT prescribe:
- Acetaminophen alone—it is ineffective for acute low back pain based on current evidence 1, 3
- Opioids as first-line therapy—evidence is limited to modest short-term effects, with known risks of addiction that far outweigh benefits for musculoskeletal pain 1, 2
- Systemic corticosteroids—they are not effective for low back pain 1
- Benzodiazepines—they are ineffective for radiculopathy and not recommended 1
Multimodal Strategy for Immobility
Given the patient's limited mobility, implement these non-pharmacologic adjuncts simultaneously:
- Ice application and elevation for acute inflammation 4
- Heat therapy to improve local circulation and produce muscle relaxation 5
- Transcutaneous electrical nerve stimulation (TENS) if available 4
The immobility itself is a concern—this patient is at risk for deconditioning and chronicity. Address anxiety about movement, as fear-avoidance can perpetuate disability.
Duration and Monitoring
- Prescribe NSAIDs at the lowest effective dose for the shortest necessary duration to minimize gastrointestinal and cardiovascular risks 5, 2
- Reassess within one week—both NSAIDs and muscle relaxants show effectiveness at approximately one week for acute pain 3
- If pain persists beyond 12 weeks (becomes chronic), consider duloxetine, which has modest evidence for chronic low back pain 1
Critical Caveat
The shoulder pain component may benefit from similar NSAID therapy 6, but if there's concern for rotator cuff pathology requiring surgical repair, NSAIDs may need to be avoided due to concerns about healing in select patients 6. Clarify the shoulder diagnosis before committing to prolonged NSAID use if surgery is contemplated.
The evidence consistently shows that pain relief from these medications is small to moderate and generally short-term, with improvements in function being even smaller 1. Set realistic expectations with your patient—these medications provide symptomatic relief but do not address underlying causes.